持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/09/24 | 3,340 | 3,340 | 3,280 | 3,280 | -20 | -0.6% | 51,800 |
| 2026/09/18 | 3,340 | 3,340 | 3,300 | 3,300 | -30 | -0.9% | 51,600 |
| 2026/09/17 | 3,285 | 3,330 | 3,275 | 3,330 | +60 | +1.8% | 57,600 |
| 2026/09/16 | 3,260 | 3,290 | 3,225 | 3,270 | +20 | +0.6% | 37,200 |
| 2026/09/15 | 3,225 | 3,265 | 3,225 | 3,250 | +25 | +0.8% | 35,100 |
| 2026/09/14 | 3,160 | 3,235 | 3,160 | 3,225 | +65 | +2.1% | 28,900 |
| 2026/09/11 | 3,140 | 3,170 | 3,135 | 3,160 | -15 | -0.5% | 56,700 |
| 2026/09/10 | 3,170 | 3,190 | 3,165 | 3,175 | -5 | -0.2% | 33,900 |
| 2026/09/09 | 3,190 | 3,205 | 3,175 | 3,180 | -5 | -0.2% | 33,700 |
| 2026/09/08 | 3,200 | 3,225 | 3,175 | 3,185 | -20 | -0.6% | 29,600 |
| 2026/09/07 | 3,250 | 3,250 | 3,200 | 3,205 | -50 | -1.5% | 31,300 |
| 2026/09/04 | 3,280 | 3,285 | 3,245 | 3,255 | -30 | -0.9% | 42,200 |
| 2026/09/03 | 3,295 | 3,315 | 3,280 | 3,285 | +5 | +0.2% | 33,600 |
| 2026/09/02 | 3,290 | 3,315 | 3,280 | 3,280 | -30 | -0.9% | 41,500 |
| 2026/09/01 | 3,285 | 3,325 | 3,280 | 3,310 | +30 | +0.9% | 31,400 |
| 2026/08/31 | 3,270 | 3,300 | 3,270 | 3,280 | -10 | -0.3% | 87,200 |
| 2026/08/28 | 3,290 | 3,320 | 3,280 | 3,290 | ±0 | ±0% | 40,200 |
| 2026/08/27 | 3,335 | 3,335 | 3,280 | 3,290 | -45 | -1.3% | 35,400 |
| 2026/08/26 | 3,305 | 3,340 | 3,300 | 3,335 | +25 | +0.8% | 38,700 |
| 2026/08/25 | 3,265 | 3,315 | 3,265 | 3,310 | +45 | +1.4% | 52,000 |
| 2026/08/24 | 3,285 | 3,305 | 3,260 | 3,265 | +5 | +0.2% | 35,000 |
| 2026/08/21 | 3,280 | 3,285 | 3,250 | 3,260 | -20 | -0.6% | 43,700 |
| 2026/08/20 | 3,240 | 3,280 | 3,230 | 3,280 | +60 | +1.9% | 58,900 |
| 2026/08/19 | 3,225 | 3,235 | 3,190 | 3,220 | ±0 | ±0% | 42,500 |
| 2026/08/18 | 3,190 | 3,240 | 3,190 | 3,220 | +25 | +0.8% | 35,800 |
| 2026/08/17 | 3,255 | 3,255 | 3,180 | 3,195 | -55 | -1.7% | 42,500 |
| 2026/08/14 | 3,240 | 3,260 | 3,230 | 3,250 | ±0 | ±0% | 40,400 |
| 2026/08/13 | 3,225 | 3,250 | 3,215 | 3,250 | +25 | +0.8% | 33,400 |
| 2026/08/12 | 3,250 | 3,250 | 3,215 | 3,225 | -15 | -0.5% | 38,900 |
| 2026/08/10 | 3,230 | 3,250 | 3,205 | 3,240 | +30 | +0.9% | 38,700 |
| 2026/08/07 | 3,135 | 3,230 | 3,125 | 3,210 | +75 | +2.4% | 68,900 |
| 2026/08/06 | 3,100 | 3,150 | 3,090 | 3,135 | +65 | +2.1% | 89,100 |
| 2026/08/05 | 3,145 | 3,150 | 3,070 | 3,070 | -50 | -1.6% | 93,300 |
| 2026/08/04 | 3,175 | 3,175 | 3,090 | 3,120 | -60 | -1.9% | 128,000 |
| 2026/08/03 | 3,170 | 3,245 | 3,075 | 3,180 | +60 | +1.9% | 143,900 |
| 2026/07/31 | 3,240 | 3,245 | 3,120 | 3,120 | -110 | -3.4% | 68,900 |
| 2026/07/30 | 3,245 | 3,255 | 3,180 | 3,230 | -15 | -0.5% | 66,200 |
| 2026/07/29 | 3,195 | 3,270 | 3,175 | 3,245 | +60 | +1.9% | 71,600 |
| 2026/07/28 | 3,190 | 3,200 | 3,160 | 3,185 | -10 | -0.3% | 51,600 |
| 2026/07/27 | 3,155 | 3,200 | 3,145 | 3,195 | +75 | +2.4% | 66,300 |
| 2026/07/24 | 3,120 | 3,135 | 3,105 | 3,120 | ±0 | ±0% | 44,900 |
| 2026/07/23 | 3,140 | 3,140 | 3,105 | 3,120 | -20 | -0.6% | 65,200 |
| 2026/07/22 | 3,145 | 3,165 | 3,125 | 3,140 | -5 | -0.2% | 58,700 |
| 2026/07/21 | 3,135 | 3,170 | 3,115 | 3,145 | +30 | +1% | 66,800 |
| 2026/07/17 | 3,120 | 3,145 | 3,100 | 3,115 | +5 | +0.2% | 51,600 |
| 2026/07/16 | 3,155 | 3,175 | 3,110 | 3,110 | -30 | -1% | 53,800 |
| 2026/07/15 | 3,130 | 3,155 | 3,120 | 3,140 | +25 | +0.8% | 52,900 |
| 2026/07/14 | 3,130 | 3,150 | 3,110 | 3,115 | +5 | +0.2% | 54,200 |
| 2026/07/13 | 3,155 | 3,155 | 3,110 | 3,110 | -25 | -0.8% | 62,300 |
| 2026/07/10 | 3,160 | 3,160 | 3,130 | 3,135 | +5 | +0.2% | 49,100 |
1～
50
件表示中 / 4031件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 328,000円 | +7.7% | +11.7% | 2.59% | 11.54倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 科研薬 | 396,500円 | +17.0% | - | 4.79% | 23.10倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ペプチド | 105,650円 | +72.8% | - | 0.00% | 45.29倍 | 2.80倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ネクセラファーマ | 126,700円 | +39.5% | - | 0.00% | 21.05倍 | 1.79倍 |
|
創薬ベンチャー老舗。買収で成長。低分子で定評の英国創薬事業、日本の製造販売が事業２本柱 |
| ゼリア新薬 | 201,300円 | +6.6% | +17.7% | 2.48% | 8.87倍 | 0.82倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
